SARS-COV-2 ACUTE RESPIRATORY DISEASE
Clinical trials for SARS-COV-2 ACUTE RESPIRATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 ACUTE RESPIRATORY DISEASE trials appear
Sign up with your email to follow new studies for SARS-COV-2 ACUTE RESPIRATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New booster shot tested as potential COVID-19 defense
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 booster vaccine called PHH-1V. Researchers compared it to the Pfizer booster shot in adults who were already fully vaccinated. The goal was to see if the new vaccine was as safe and effective at triggering an immune response, including against new…
Matched conditions: SARS-COV-2 ACUTE RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:18 UTC
-
Heartburn & arthritis drugs tested as potential COVID-19 fighters
Disease control CompletedThis trial tested whether a combination of two existing drugs (famotidine and celecoxib) could help hospitalized COVID-19 patients recover faster and prevent severe illness in newly infected people. The study was small, with only 4 total participants, and aimed to see if this dru…
Matched conditions: SARS-COV-2 ACUTE RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC